Chronic Myelogenous Leukemia News and Research

RSS
Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. According to the American Cancer Society, CML is a type of cancer that starts in blood-forming cells of the bone marrow and then invades the blood. It can spread to the lymph nodes, spleen, liver, and other parts of the body. CML can also change into a fast-growing acute leukemia that invades almost any organ in the body.
Avillion enrolls patients in BFORE Phase III trial to treat chronic myelogenous leukemia

Avillion enrolls patients in BFORE Phase III trial to treat chronic myelogenous leukemia

DelMar presents updated VAL-083 Phase I/II trial data at GBM2015 meeting

DelMar presents updated VAL-083 Phase I/II trial data at GBM2015 meeting

New NCCN Guidelines for Patients and NCCN Quick Guide for Kidney Cancer published

New NCCN Guidelines for Patients and NCCN Quick Guide for Kidney Cancer published

DelMar closes on $2.6 million registered direct placement

DelMar closes on $2.6 million registered direct placement

DelMar obtains additional funding to support ongoing research project with lead product candidate VAL-083

DelMar obtains additional funding to support ongoing research project with lead product candidate VAL-083

New study reveals protein's critical role in development and progression of AML

New study reveals protein's critical role in development and progression of AML

Researchers identify five recurrent fusion genes involved in acute gastritis and cancer

Researchers identify five recurrent fusion genes involved in acute gastritis and cancer

PolyU develops novel big data analysis platform for analyzing interactions among cancer genes

PolyU develops novel big data analysis platform for analyzing interactions among cancer genes

Additional preclinical data on DelMar’s VAL-083 to treat temozolomide-resistant GBM presented at AACR

Additional preclinical data on DelMar’s VAL-083 to treat temozolomide-resistant GBM presented at AACR

DelMar to present new data on development of VAL-083 at 2015 ASCO Annual Meeting

DelMar to present new data on development of VAL-083 at 2015 ASCO Annual Meeting

Low doses of imatinib drug can push immune system to combat bacterial infections

Low doses of imatinib drug can push immune system to combat bacterial infections

TSRI scientists identify enzyme that maintains healthy periods of inactivity in HSCs to prevent anemia

TSRI scientists identify enzyme that maintains healthy periods of inactivity in HSCs to prevent anemia

ItpkB enzyme regulates stem cells function to prevent cancer, anemia

ItpkB enzyme regulates stem cells function to prevent cancer, anemia

NCCN panelists discuss on evidence-based decision-making at bedside

NCCN panelists discuss on evidence-based decision-making at bedside

New NCCN Guidelines for treating Acute Lymphoblastic Leukemia

New NCCN Guidelines for treating Acute Lymphoblastic Leukemia

VAL-083 drug compound shows promise against non-small cell lung cancer

VAL-083 drug compound shows promise against non-small cell lung cancer

Avillion initiates BOSULIF Phase 3 trial in patients with chronic phase Ph+ CML

Avillion initiates BOSULIF Phase 3 trial in patients with chronic phase Ph+ CML

Mirna enrolls first patient in hematological malignancy cohort of MRX34 Phase 1 clinical trial

Mirna enrolls first patient in hematological malignancy cohort of MRX34 Phase 1 clinical trial

ASCO: DelMar presents interim data from VAL-083 clinical trial in refractory GBM

ASCO: DelMar presents interim data from VAL-083 clinical trial in refractory GBM

Teva's SYNRIBO for injection receives FDA approval for home administration

Teva's SYNRIBO for injection receives FDA approval for home administration